Try our Advanced Search for more refined results

Sterlization Device Essure Stays On While Bayer Studies Risks

By Sindhu Sundar ( February 29, 2016, 11:17 PM EST) -- The U.S. Food and Drug Administration allowed Bayer AG to continue marketing its controversial permanent birth control device Essure amid thousands of reports of serious health problems linked to the device, including perforation of the uterus and fallopian tubes, but asked the drugmaker Monday to conduct a new clinical study on its risks....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!